Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Ptc Therapeutics (PTCT) over the last 13 years, with Q3 2025 value amounting to 0.44%.

  • Ptc Therapeutics' Return on Capital Employed rose 5400.0% to 0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year increase of 5400.0%. This contributed to the annual value of 0.25% for FY2024, which is 1200.0% up from last year.
  • According to the latest figures from Q3 2025, Ptc Therapeutics' Return on Capital Employed is 0.44%, which was up 5400.0% from 0.36% recorded in Q2 2025.
  • Over the past 5 years, Ptc Therapeutics' Return on Capital Employed peaked at 0.45% during Q1 2025, and registered a low of 0.8% during Q3 2023.
  • Over the past 5 years, Ptc Therapeutics' median Return on Capital Employed value was 0.26% (recorded in 2021), while the average stood at 0.21%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by -5400bps in 2023, then soared by 7400bps in 2025.
  • Over the past 5 years, Ptc Therapeutics' Return on Capital Employed (Quarter) stood at 0.26% in 2021, then crashed by -42bps to 0.36% in 2022, then decreased by -24bps to 0.45% in 2023, then surged by 44bps to 0.25% in 2024, then skyrocketed by 273bps to 0.44% in 2025.
  • Its last three reported values are 0.44% in Q3 2025, 0.36% for Q2 2025, and 0.45% during Q1 2025.